HARBIN, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer, and marketer of a variety of cactus-based products in China, announced today that senior members of the company's management team will attend investor conference and meet with U.S. investors in September 2009.
Conference and roadshow details:
The company will present at the Rodman & Renshaw conference from September 9-11, 2009 in New York.
CEO Jinjiang Wang will then meet with institutions from September 14-18, 2009 in New York and Los Angeles. It will be his first visit to the U.S. since the company went public in 2005.
Wang said, "We have been very pleased with the support from American investors. Our company is growing at an excellent rate as Chinese consumers increasingly accept the value of our cactus products. Revenue for the second quarter of 2009 increased 30% to $6.5 million from $5.0 million in the second quarter of 2008. Diluted earnings per share for the quarter was $0.07 based on a net income of $1.4 million, compared to a net income of $1.0 million or $0.06 diluted EPS last year. I look forward to an opportunity to further explain our business model and cacti nutritional value to interested parties and to thank those that have supported our activities."
Those interested in meeting with the management team during the visit should contact Susan Zhou, Hawk Associates, at 305-451-1888, e-mail: email@example.com.
About China Kangtai Cactus Biotech, Inc.
China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: firstname.lastname@example.org.
An investment profile on China Kangtai Cactus Biotech Inc. is available at http://www.hawkassociates.com/profile/ckgt.cfm . For an online investor relations kit, visit http://www.hawkassociates.com . For more investor-related questions, contact Susan Zhou, Hawk Associates, at 305-451-1888, e-mail: email@example.com. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact: Hawk Associates Susan Zhou Tel: +1-305-451-1888 Email: firstname.lastname@example.org
|SOURCE China Kangtai Cactus Biotech, Inc.|
Copyright©2009 PR Newswire.
All rights reserved